Skip to main content
. 2020 Oct 12;8(2):e001486. doi: 10.1136/jitc-2020-001486

Table 2.

Most common treatment-related adverse events in oncolytic virus clinical trials

Adverse event Low grade (1–2) High grade (3–4) Total
Fever 56 4 60
Chills/rigors 40 0 40
Nausea/vomiting 30 8 38
Flu-like symptoms 27 2 29
Fatigue 36 4 40
Injection site pain 15 0 15
Other pain 19 7 26

*Number of studies reporting the listed event